Seasonal Influenza Market Outlook, Trends And Future Opportunities (2024-2031)

Download FREE Sample Customize As Per Need Buy Now
  1. home
  2. Report Store
  3. Seasonal Influenza Market

Seasonal Influenza Market Outlook, Trends And Future Opportunities (2024-2031)

Seasonal Influenza Market, By Vaccine Type (Inactivated, Live Attenuated, Recombinant, Others), By Technology (Egg-based, Cell-based, Recombinant, Others), By Age Group (Pediatric, Adult), By Distribution Channel (Hospitals, Clinics, Pharmacies, Others), By Valence (Trivalent, Quadrivalent, Other multivalent), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Mar 2024
  • Author(s): Sagar Karlekar
  • Report ID: IDA71
  • Region: Global
  • Format: PDF/EXCEL
Press Release: Seasonal Influenza Market is Forecasted to Hit US$ 10.0 Bn By 2031 | CAGR 5.5%

Table of Contents:

  • Chapter 1. Research Methodology and Scope
    • Market Segmentation and Scope
    • Regional Coverage
    • Objectives
    • Research Methodology
  • Chapter 2. Executive Summary
    • Market Overview
    • Key Market Trends
    • Market Drivers and Restraints
    • Market Size and Forecast
    • Segmental Analysis
    • Competitive Analysis
  • Chapter 3. Seasonal Influenza Vaccine Type Segment Analysis
    • Vaccine Type Market Size and Forecast
    • Vaccine Type Segment Overview
    • Key Vaccines Analysis
    • Vaccine Type Market Drivers
      • Rising demand for cell-based and recombinant vaccines
      • Introduction of newer multivalent vaccines
      • Funding for novel vaccine technologies
    • Vaccine Type Market Restraints
      • Premium pricing of newer vaccines
      • Limitations of traditional egg-based vaccines
  • Chapter 4. Seasonal Influenza Technology Segment Analysis
    • Technology Market Size and Forecast
    • Technology Segment Overview
    • Leading Technologies Adopted
    • Technology Market Drivers
      • Shift from egg-based to cell-based and recombinant methods
      • Investments in faster, scalable technologies
      • Technological improvements enabling enhanced productivity
    • Technology Market Restraints
      • High capital costs of new production methods
      • Complexities in scaling up new technologies
  • Chapter 5. Delirium Treatment Drugs Market: Regional Market Trends, Size, and Future Outlook
    • North America
      • Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Market Drivers and Restraints
    • Europe
      • Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Market Drivers and Restraints
    • Asia Pacific
      • Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Market Drivers and Restraints
    • Latin America
      • Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Market Drivers and Restraints
    • Middle East & Africa
      • Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2023-2031)
      • Market Drivers and Restraints
  • Chapter 6. Seasonal Influenza Competitive Analysis
    • GlaxoSmithKline
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Sanofi Pasteur
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Seqirus
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • AstraZeneca
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Novartis
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Abbott
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • F. Hoffmann-La Roche
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Merck & Co.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Becton Dickinson
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Quidel Corporation
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
  • Chapter 6.
    • Research Methodology
    • Primary Research
    • Secondary Research
    • Assumptions
    • IDataAcumen Analysis
    • Paid Databases
  • Appendix
    • About Us

Frequently Asked Questions

The current market size of the seasonal influenza industry is around $6.5 billion in 2023.

Rising disease burden and influenza pandemics threats, Advances in cell-based and recombinant vaccine technologies, Use of adjuvants and high-dose vaccines for better efficacy, Introduction of quadrivalent and higher valency vaccines, Growing demand from emerging markets, Increased recommendation of flu vaccines for broader populations

Inactivated vaccines segment.

The market is expected to grow at a CAGR of 5.5% from 2023 to 2031, reaching $10.0 billion by 2031.

Rising disease burden of influenza, Need for improved vaccines with broader, longer-lasting protection, Advances in cell-based and recombinant vaccine technologies, Use of adjuvants and high-dose vaccines for better efficacy, Introduction of quadrivalent and higher valency vaccines
Download FREE Sample Buy Now